Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Epigenetics|July 1, 2020
BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant gliomaElisa Funck-Brentano, Dzeneta Vizlin-Hodzic, Jonas A Nilsson, et al.
Current Opinion in Lipidology|September 5, 2008
Nuclear factor of activated T-cells transcription factors in the vasculature: the good guys or the bad guys?Lisa M Nilsson, Jenny Nilsson-Ohman, Anna V Zetterqvist, et al.
Blood|January 31, 2009
Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabineAndreas Höglund, Lisa M Nilsson, Linus Plym Forshell, et al.
Cancer Research|October 20, 2004
Id2 is dispensable for myc-induced lymphomagenesisJonas A Nilsson, Lisa M Nilsson, Ulrich Keller, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2006
High glucose activates nuclear factor of activated T cells in native vascular smooth muscleJenny Nilsson, Lisa M Nilsson, Yung-Wu Chen, et al.
Melanoma Research|November 10, 2021
Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanomaVasu R Sah, Joakim Karlsson, Henrik Jespersen, et al.
Plos Genetics|March 23, 2012
Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during tumorigenesisLisa M Nilsson, Tacha Zi Plym Forshell, Sara Rimpi, et al.
Pageof 4